Home › Encyclopedia › Melanotan II: Research Status and Trial Overview
Research / Unapproved

Melanotan II: Research Status and Trial Overview

Molecular formulaC50H69N15O9
Molecular weight1024.2 g/mol
Registered trials1
PubChem CID92432

What Melanotan II Is

Melanotan II is a synthetic peptide (molecular formula C50H69N15O9) with a PubChem CID of 92432. It has no FDA-approved label, no approved brand name, and no established indications. It is classified here as an unapproved research compound, meaning any use outside of a registered clinical trial falls outside regulatory oversight.

Clinical Trial Footprint

There is one registered clinical trial listed for melanotan II. That study, NCT07437560, is examining melanotan II as an adjunct to NB-UVB phototherapy for repigmentation in stable nonsegmental vitiligo. It is currently recruiting participants. Because this is the only registered trial, publicly available controlled data on the compound remain limited.

FAQ

Is melanotan II FDA-approved?
No. Melanotan II has no FDA-approved label, no approved brand name, and no approved indications. It is classified as an unapproved research compound.
What is melanotan II being studied for?
The one registered clinical trial is investigating melanotan II as an adjunct to NB-UVB phototherapy for repigmentation in people with stable nonsegmental vitiligo. This trial is currently in the recruiting stage.
How many clinical trials involve melanotan II?
Public trial registries list a single clinical trial for melanotan II as of the most recent data pull. This limits the amount of controlled human data currently available on the compound.
Are there known side effects reported for melanotan II?
No FAERS adverse event reports were available for melanotan II in the data reviewed. This does not mean side effects do not occur, only that this particular dataset had no reports to summarize.
What is the chemical identity of melanotan II?
Melanotan II is a synthetic peptide with the molecular formula C50H69N15O9 and a molecular weight of approximately 1024.2. It is catalogued in PubChem under CID 92432.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 92432 ClinicalTrials.gov (NCT07437560)

Updated 2026-09-19